EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation with Clinical Characteristics and Possible Mechanisms

ConclusionEZH2 overexpression is associated with worse outcomes among multiple myeloma patients from the CoMMpass study. Its known association with p53 and other drivers of malignancy support further lab-based and clinical study in multiple myeloma.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research